急性下壁心肌梗死病人急诊PCI术中 出现无复流的相关危险因素探讨 |
| |
引用本文: | 刘晓玲. 急性下壁心肌梗死病人急诊PCI术中 出现无复流的相关危险因素探讨[J]. 蚌埠医学院学报, 2019, 44(2): 260-263. DOI: 10.13898/j.cnki.issn.1000-2200.2019.02.036 |
| |
作者姓名: | 刘晓玲 |
| |
作者单位: | 内蒙古医科大学附属医院 急诊科,内蒙古 呼和浩特,010059 |
| |
摘 要: | 目的探讨急性下壁心肌梗死病人直接经皮冠状动脉介入治疗(percutaneous coronary intervention,PCI)中无复流的发生情况及其危险因素。方法收集126例急性下壁心肌梗死行急诊PCI治疗病人的病历资料,采用logistic回归分析无复流发生的相关危险因素。结果126例急性下壁心肌梗死病人均成功进行急诊PCI治疗,其中有16例发生无复流,发生率12.70%。多因素logistic回归分析结果显示,急性下壁心肌梗死病人急诊PCI术中出现无复流的危险因素为糖尿病(OR=1.647,95%CI:1.242~1.845,P < 0.05)、发病至急诊PCI时间(OR=5.281,95%CI:2.782~10.018,P=0.002)、术前TIMI血流分级(≤1级)(OR=2.735,95%CI:1.040~3.062,P=0.020)和术前收缩压(OR=1.844,95%CI:1.153~3.638,P=0.015)。结论无复流在急性下壁心肌梗死病人急诊PCI术中具有较高的发生率,应对无复流发生的相关影响因素采取有效的预防措施,降低PCI术中出现无复流的风险。
|
关 键 词: | 急性下壁心肌梗死 无复流 经皮冠状动脉介入治疗术 危险因素 |
收稿时间: | 2016-08-30 |
Analysis of the related risk factor of no-reflow in patients with acute inferior myocardial infarction during PCI |
| |
Affiliation: | Department of Emergency, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot Inner Mongolia 010059, China |
| |
Abstract: | ObjectiveTo investigate the risk factors of no-reflow in patients with acute inferior myocardial infarction during percutaneous coronary intervention(PCI).MethodsThe data of 126 acute inferior myocardial infarction patients treated with PCI were investigated, and the related risk factors of no-reflow were analyzed.ResultsOne hundred and twenty-six patients with acute inferior myocardial infarction were successfully treated with PCI, no-reflow in 16 cases were found, and the incidence rate of which was 12.70%.Logistic regression analysis showed that the diabetes(OR=1.047, 95%CI:1.019 to 1.233, P=0.036), reperfusion time(OR=5.281, 95%CI:2.782 to 10.018, P=0.002), TIMI flow grading before PCI(OR=1.735, 95%CI:1.040 to 3.062, P=0.020) and low systolic blood pressure before PCI(OR=1.844, 95%CI:1.153 to 3.638, P=0.015) were the risk factors of no-reflow.ConclusionsThe incidence of no-reflow in acute inferior myocardial infarction patients is high.The effectively preventive measures against the related risk factor of no-reflow should be implemented, which can reduce the no-reflow risk of PCI. |
| |
Keywords: | |
本文献已被 万方数据 等数据库收录! |
| 点击此处可从《蚌埠医学院学报》浏览原始摘要信息 |
|
点击此处可从《蚌埠医学院学报》下载全文 |
|